Loading...
skip to Main Content

Now with over 4,500 members from all over the world, EASL is an influential international organisation. It attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in European liver policy.

Leadership & Governance

Governing Board

The EASL Governing Board is composed of 11 scientific experts. The EASL Governing Board is dedicated to the pursuit of excellence in hepatology, liver research and the clinical practice of liver disorders.

The Governing Board has the following duties: Read more

Secretary General

The Secretary General is the Chief Executive of the association for a period of two years having already served as Vice-Secretary.

Professor Phil Newsome

Director of the Centre for Liver and Gastrointestinal Research & Professor of Hepatology, University of Birmingham, and Consultant Hepatologist at the Liver Unit, Queen Elizabeth Hospital, Birmingham.

Vice-Secretary

The Vice-Secretary serves for two years in close collaboration with the Secretary General and will become the next Secretary General in term.

Prof. Thomas Berg

Head of the Section of Hepatology Acting Director of the Clinic of Gastroenterology University Hospital Leipzig, Germany

Treasurer

The Treasurer has been elected by the EASL assembly as a non-voting member of the Governing Board for a second term of five years. All Governing Board members share responsibility for the society’s finances.

Prof. Francesco Negro

Divisions of Gastroenterology and Hepatology of Clinical Pathology, University Hospital of Geneva

Educational Councillors

The Educational Councillor was elected for a 4-year term by the EASL Assembly.

Prof. Ulrich Beuers

EASL Educational Councillor-Elect, Department of Gastroenterology & Hepatology Tytgat Institute for Liver and Intestinal Research

EU Policy Councillor

The EU Policy Councillor position was approved as a 5-year position during the General Assembly in Vienna, Austria on 17 April 2010. Prof. Maria Buti is now EU Policy Councillor-Elect and will be shadowing Prof. Helena Cortez-Pinto for the following year, until April 2020.

Prof. Helena Cortez-Pinto

Director of Clínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de Lisboa, and Coordinator of the Hepatology Unit of the Gastroenterology Department of Hospital de Santa Maria/Centro Hospitalar Lisboa Norte, Portugal. She is the Policy Councillor for EASL EU affairs, since April 2016.

Prof. Maria Buti

Professor of Medicine Chief of the Internal Medicine and Hepatology Department Hospital General Universitari Valle Hebron, Barcelona, Spain

Scientific Committee members

There are six Scientific Committee members. All of them are elected by the EASL Assembly for a period of three years.

Prof. Maria Reig

EASL Scientific Committee (Chair)
BCLC group
Liver Unit. Hospital Clínic of Barcelona
University of Barcelona
IDIBAPS. CIBERehd

Prof. Markus Cornberg

Managing Director Competence Network for Viral Hepatitis, Med. Secretary German Liver Foundation

Prof. Pierre-Emmanuel Rautou

University of Paris-Diderot and Hôpital Beaujon of Clichy, France

Dr. Emma Andersson

Assistant Professor and Principal Investigator, Karolinska Institutet, Sweden

Dr. Emmanuel Tsochatzis

Associate Professor and Consultant Hepatologist UCL Institute for Liver and Digestive Health Royal Free Hospital, London, United Kingdom

Prof. Luca Valenti

Associate Professor of Internal Medicine University of Milan, Italy
Back To Top